Background: Obesity seem to regulate peri-implant health. It is proposed that peri-implant cre-
| INTRODUCTION
Obesity is rising globally and has become a serious public health dilemma. Epidemiologists have reported that obesity is particularly escalating in the developing world. 1 The explosion of overweight and obesity in developing world has increased the risk of heart diseases, stroke, diabetes mellitus, and certain types of cancers. 2, 3 This metabolic condition occurs because of the altered energy imbalance when intake is higher than consumption that subsequently leads to adipose tissue accumulation. 4 Peri-implantitis is a chronic inflammatory disease which is described by the presence of bleeding on probing (BOP) and/or suppuration, deepened peri-implant sulcus (>4 mm) and crestal bone loss (CBL; ≥2 mm). 5, 6 It is assumed that the risk indicators involved in the pathogenesis of periodontal disease also contribute to peri-implant infections. 7 The primary etiology is the colonization of the oral bacteria to form pathogenic 2 | MATERIALS AND METHODS
| Participants and ethical procedure
The current clinico-laboratory study adheres to the principles described by the Declaration of Helsinki that were revised in 2013 for research involving human subjects. All participants filled the information sheet that described the details of the research purpose and techniques of the current study. Recruited patients were: 
| Serum investigations
Serum lipid analysis that included the evaluation of triglycerides, total cholesterol, high density lipoprotein, low density lipoprotein, and glucose parameters, including fasting blood glucose levels (FBGL), insulin, and homeostasis model assessment of insulin resistance (HOMA-IR) were measured from the serum samples of both the groups. HOMA-IR was estimated using the following mathematical
formulate. 18 The HOMA-IR score that exceeded 2.7 projected insulin resistance. 
| Clinical periodontal and peri-implant assessments

| Standardized digital x-rays
Radiographic data was recorded by an expert and calibrated assessor. Radiographs were taken as described in our previous studies. 20 Digital periapical radiographs were studied incorporating in a special- 
| Collection of PICF and measurement of biomarkers
Peri-implant sites were carefully cleaned from supragingival deposits and isolated with sterile gauze and dried using air syringe.
PICF samples were collected using standard paper strips 
| Statistical proposal and analysis
Normal distribution of the dependent variables was computed using Shapiro-Wilk tests. Significance of comparisons between groups of means was tested using two-sample t-test. Bonferroni post hoc adjustment was tested for multiple comparisons. Pearson correlation analysis was carried out for correlation between biomarker levels and clinical peri-implant indices by evaluating the correlation coefficient.
P value less than .05 was regarded as significant.
| RESULTS
Twenty-five number of obese (13 males and 12 females) and nonobese (14 males and 11 females) patients were included and divided in two groups, respectively. The mean age of obese individuals was 61 years whereas the mean age of nonobese individuals was 59 years. Forty-three dentals implants were evaluated in obese patients, whereas a total of 39 dental implants were examined in nonobese patients. Implants in service averaged 5.7 years in obese as compared to nonobese patients (P = .022; Table 2 ).
PICF volume and levels of IL-1β ad IL-6 were found to be higher in obese patients than nonobese (Table 3) . Pearson correlation analysis revealed IL-1β was positively correlated with CBL (P = .0079), whereas IL-6 showed positive correlation with both BOP (P = .0019) and CBL (P = .015) among obese patients (Table 4) .
| DISCUSSION
Although recent data has investigated about peri-implant health among patients with obesity, 14, 21 little is known about proinflammatory biomarker levels that may help researchers to extrapolate the pathological role of overweight, such as obesity, in peri-implant inflammation. This study aimed to quantify the levels of biomarkers and elucidate the association of obesity and peri-implant health on the biomolecular level. The findings of the current study revealed that peri-implant indices including PI, BOP, CBL, and proinflammatory biomarkers were significantly higher in obese patients compared with nonobese subjects. The probable pathological mechanism that modulates periimplant health around dental implants in overweight individuals can be clarified by the increased systemic inflammatory burden in obesity. 17, 18 Obesity is associated with increased amount of body fat. The adipocyte cells are responsible for the amplified levels of proinflammatory cytokines that are released from the cells itself and macrophages that are relatively increased in obesity. 22 It is note-worthy that CBL was found to be significantly higher among obese patients as compared to nonobese. It is proved by the recent experimental study by Fujita and Maki that obese mice fed with high amounts of fat can lead to increase alveolar bone loss. 23 Interestingly, PICF levels of IL-1β
were found raised in obese patients. Research suggests that IL-1β is a well-known biomarker for alveolar bone destruction. 24, 25 These hypotheses could explain the plausible associations of increased bone loss around dental implants in obesity.
Worthy-of-note, scores of clinical peri-implant and periodontal indices including PI and BOP were higher in obese patients than nonobese. This is indicated by the neglected attitudes of oral hygiene measures by obese individuals. Our data indicates that only 26% of obese subjects brush twice daily. A study by Franchini et al. 26 proposed that obese adults showed irregular patterns of toothbrushing behavior. Moreover, a recent meta-analysis by Khan et al. 27 revealed that obesity indicators including BMI, waist circumference and body fat percentage were positively associated with clinical parameters such as BOP and plaque scores. This is also explained by the increased PD in obese patients. Although PD in obese group was higher as compared to nonobese, these differences did not show statistical difference and these pockets cannot be considered pathological as the scores were < 4 mm. It is suggested that overweight patients with higher and deep PD harbor enhanced percentage levels of bacteria causing periodontal diseases. 28 Although the direct cause-effect of this link needs validation, it is contemplated that obesity-associated immune changes in peri-implant structures may alter the pocket environment and/or host defenses, affecting the subgingival bacterial niche around dental implants. Future studies should be undertaken in order to prove the microbiological/immune-inflammatory process of peri-implant probing sites in obese patients.
In chronic hyperglycemia, numerous proteins undergo a nonenzymatic glycosylation, resulting in accumulated glycation end products (AGEs). There is ample data that indicates chronic hyperglycemic state is associated with excess formation of AGEs which are responsible for periodontal and peri-implant tissue destruction. 29, 30 These proteins surmount impaired fibroblastic growth and causes considerable increase in the formation and expression of destructive proinflammatory cytokines including IL-6 and IL-1β. 31 Moreover, it is suggested that chronic hyperglycemia impairs the chemotactic and phagocytic function of neutrophils (which prevent destruction of bacteria in periodontal pockets), thereby increasing tissue destruction. 32 It is noted that in the current study, mean FBGL among obese patients was 122.4 mg/dL which indicates prediabetes. Therefore, it is supposed that the increased levels of proinflammatory cytokines and increased amount of peri-implant destruction may be partly explained by the AGEs and partly by the oxidative stress (induced as a result of hyperglycemia). 33, 34 The robust element of the current study lies in its evaluation of the two biomarker levels which are considered proinflammatory and destructive in nature and are implicated in causing hard and soft tissue inflammation around the dental implants. In this way, the current study pushes the association of obesity and how it modulates periimplant tissue inflammation into a new direction. This allows us to extrapolate the assessment of an important risk factor such as obesity and overweight that may cause dental implant failure.
| CONCLUSION
Clinical peri-implant parameters were worse and proinflammatory biomarkers were significantly higher in obese patients compared with nonobese subjects. The finding of the present study suggests that increased proinflammatory biomarkers in PICF of obese patients may modulate peri-implant inflammation around dental implants.
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